MaartenTaal United KingdomUniversity of Nottingham

MaartenTaal
Maarten Taal MBChB, MMed, MD, FCP(SA), FRCP Maarten graduated from the University of Cape Town Medical School, South Africa, in 1987. After completing his post-graduate training in internal medicine and nephrology at Groote Schuur Hospital, Cape Town, he joined the Laboratory of Kidney and Electrolyte Physiology at Brigham and Women’s Hospital, Boston, USA under the directorship of Barry M. Brenner, MD. His research focused on mechanisms underlying the progression of chronic kidney disease (CKD) and earned him a Doctor of Medicine degree. He subsequently moved to the United Kingdom. He was appointed Professor of Medicine at the University on Nottingham in 2014, where he leads the Centre for Kidney Research and Innovation. He is a Past President of the British Renal Society and current Chair of the International Network of CKD Cohorts. He is Editor-in-Chief of “Current Opinion in Nephrology and Hypertension”, Co-Editor for “Brenner and Rector’s The Kidney”, Academic Editor for “PLOS Medicine” and is on the Editorial Board for “American Journal of Kidney Diseases”.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/2df8c114b58b87552d7b674be23a539b.jpg
First Name
Maarten
Last Name
Taal
Institution
Country.
United Kingdom

Friday, February 7, 2025

Time Session
4:15 p.m.
5:15 p.m.
SK02
MaartenTaal Chair United KingdomUniversity of Nottingham
ShrutiTapiawala Chair IndiaGleneagles Hospital Mumbai , Sir HN Reliance Foundation Hospital and Research Center, Mumbai
  • Anti-nephrin Antibodies - What Do We Know and What Can We Look Forward to?
    SK02-01
    TobiasHuber Speaker GermanyUniversity Medical Center Hamburg-Eppendorf
  • Mechanism of IgA Deposition in the Mesangium: Implication for Novel Treatments
    SK02-02
    Yoshihito Nihei Speaker JapanDepartment of Nephrology, Juntendo University Faculty of Medicine
  • Lupus Nephritis: Recent Advances in Pathogenesis and New Therapeutic Approaches
    SK02-03
    LizLightstone Speaker United KingdomImperial College London
  • Q&A
    SK02-04
Brahmkamal Hall - Plenary Hall

Saturday, February 8, 2025

Time Session
11:15 a.m.
11:45 a.m.
SL11
MaartenTaal Spotlight Chairperson United KingdomUniversity of Nottingham
RobertoPecoits Filho Spotlight Chairperson United StatesArbor Research Collaborative for Health
  • Introducing iNET-CKD: Harnessing Global Cohorts to Transform CKD Research
    MaartenTaal Spotlight Speaker United KingdomUniversity of Nottingham
  • Exploring iNET-CKD Cohorts: Key Findings from iNET-CKD Studies
    RobertoPecoits Filho Spotlight Speaker United StatesArbor Research Collaborative for Health
  • Collaborative Opportunities in CKD Research: Leveraging the iNET-CKD Platform
    AdeeraLevin Spotlight Speaker CanadaUniversity of British Columbia and Providence Health Care
  • Q and A
Spotlight One (Exhibition)

Thursday, February 6, 2025

Time Session
11:30 a.m.
1:30 p.m.
NAR2
KenarJhaveri Chair United StatesNorthwell Health
MitchellRosner Chair United StatesUniveristy of Virginia Health
  • Clinical Trials Overview: Focus on GLP1a, MRA, and SGLT2
    NAR2-01
    MaartenTaal Speaker United KingdomUniversity of Nottingham
  • SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach
    NAR2-02
    KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology
  • SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach
    NAR2-03
    MadhukarMisra Speaker United StatesUniversity of Missouri Columbia, USA
  • Q and A
    NAR2-04
Neelkamal Hall 305